Showing results (1251-1260 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|May 12, 2025
Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylationRainer Wiewrodt, Maren Kloss, Johanna Jost-Engl, et al.
Neuro-Oncology Advances|July 28, 2025
Blood-brain barrier disruption following MR-guided laser interstitial thermal therapySilas H Nielsen, Jane Skjøth-Rasmussen, Vibeke A Larsen, et al.
Neuro-Oncology Advances|July 28, 2025
EZH2 overexpression is associated with aggressive behavior and promotes cell proliferation in CNS WHO grade 3 meningiomasPéter Szőke, Dániel Sztankovics, Titanilla Dankó, et al.
Neuro-Oncology Advances|July 28, 2025
Radiomics based on MRI and 18F-FDG PET/CT predicts response to EGFR-TKI therapy based on primary NSCLC and brain metastasisYing Fan, Chunna Yang, Yanjun Hu, et al.
Neuro-Oncology Advances|July 28, 2025
Impact of stereotactic radiosurgery timing relative to immune checkpoint blockade administration on brain metastasis disease and radionecrosis outcomesAnika Mittal, Aviva Green, Xavier Fitzgerald, et al.
Neuro-Oncology Advances|July 28, 2025
Aggressive pituitary tumors and pituitary carcinomas: Definition, management, and overview for clinical practiceFrancesco Calvanese, Gianpaolo Jannelli, Loic Feuvret, et al.
Neuro-Oncology Advances|July 24, 2025
Exploiting genetic and environmental vulnerabilities to target DHODH in CNS tumorsEli E Bar, Julie-Aurore Losman
Neuro-Oncology Advances|July 24, 2025
Dual targeting of CD155/TIGIT and PD-L1/PD-1 immune checkpoints potentiates NK cell-mediated cytotoxicity in medulloblastomaMatthijs Monnikhof, Michael Y Schakelaar, Chris Meulenbroeks, et al.
Neuro-Oncology Advances|August 4, 2025
Prediction of treatment failure and early identification of tumor progression after Gamma-Knife radiosurgery in vestibular schwannoma: A retrospective cohort studyLudovica Fabbrocini, Helene Hurth, Albertus T C J van Eck, et al.
Neuro-Oncology Advances|May 5, 2025
Characterizing long- and short-survival glioblastoma patients with FLT-PET/MRI and metabolomicsJan Axelsson, Benny Björkblom, Thomas Asklund, et al.
Pageof 138